Lenvatinib and Verapamil Sustained-Release Capsules
Determining the interaction of Lenvatinib and Verapamil Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib-Verdeso
- Lenvatinib-Verdrocet
- Lenvatinib-Verelan
- Lenvatinib-Verelan PM
- Lenvatinib-Veripred 20
- Lenvatinib-Vermox
- Verapamil Sustained-Release Capsules-Lenvatinib Mesylate
- Verapamil Sustained-Release Capsules-Lenvima
- Verapamil Sustained-Release Capsules-Lenvima (14 MG Daily Dose)
- Verapamil Sustained-Release Capsules-Lenvima (18 MG Daily Dose)
- Verapamil Sustained-Release Capsules-Lenvima (20 MG Daily Dose)
- Verapamil Sustained-Release Capsules-Lenvima (24 MG Daily Dose)